Bliss GVS Pharma Annual Results

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Mar-2023	Mar-2022	Mar-2021	Mar-2020	Mar-2019
Gross Sales	751.59	747.45	577.21	689.31	898.57
Excise Duty	--	--	--	--	--
Net Sales	751.59	747.45	577.21	689.31	898.57
Other Operating Income	--	--	--	--	--
Other Income	17.79	31.49	20.22	39.19	37.63
Total Income	769.37	778.95	597.43	728.49	936.20
Total Expenditure	634.27	702.71	470.56	579.37	740.93
PBIDT	135.11	76.24	126.87	149.12	195.27
Interest	10.36	4.74	5.51	7.57	4.41
PBDT	124.74	71.50	121.36	141.55	190.86
Depreciation	18.67	17.33	17.23	12.59	8.94
Minority Interest Before NP	--	--	--	--	--
Tax	40.84	35.78	28.92	36.81	56.11
Deferred Tax	(11.51)	(4.74)	1.23	(3.09)	(0.86)
Reported Profit After Tax	76.73	23.13	73.97	95.25	126.66
Minority Interest After NP	5.88	8.09	5.48	(2.01)	2.94
Net Profit after Minority Interest	70.86	15.04	68.49	97.27	123.72
Extra-ordinary Items	--	(37.81)	--	(9.56)	--
Adjusted Profit After Extra-ordinary item	70.86	52.85	68.49	106.83	123.72
EPS (Unit Curr.)	6.83	1.46	6.64	9.43	11.99
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	50	50	50	50	100
Equity	10.42	10.37	10.31	10.31	10.31
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	17.98	10.20	21.98	21.63	21.73
PBDTM(%)	16.60	9.57	21.02	20.54	21.24
PATM(%)	10.21	3.10	12.81	13.82	14.10

QuickLinks for Bliss GVS Pharma Ltd.